Brain Tumors: From Incidental Findings to Surgical Planning

How Brain Tumors Are First Noticed: Common Presenting Signs

Brain tumors are sometimes found after symptoms bring someone to medical attention, and sometimes they are discovered “incidentally” (for example, an MRI done for dizziness or after a minor head injury). Symptoms usually come from one or more of these effects: irritation of brain tissue, pressure on nearby structures, swelling (edema), or blockage of normal fluid pathways.

Seizures

A first-time seizure in an adult is a common way brain tumors are discovered. Tumors can irritate the cortex (the brain’s outer layer), making it electrically unstable.

• What it can feel like: a convulsion, a brief “blank out,” sudden confusion, unusual smells/tastes, déjà vu, lip smacking, or jerking of one arm/leg.
• Why it matters for planning: seizure history influences medication choices, driving restrictions, and how urgently the team pursues diagnosis and treatment.

Headaches

Headaches from a tumor are not always severe, and many people with brain tumors have no headache at all. When headaches are tumor-related, they often reflect pressure changes or swelling.

• Concerning patterns: progressively worsening over weeks, worse in the morning, worse with coughing/straining, associated with nausea/vomiting, or accompanied by new neurologic symptoms.
• Practical note: clinicians look for the combination of headache plus neurologic change, not headache alone.

Focal neurologic deficits

“Focal” means tied to a specific brain region. A tumor can disrupt the function of the area it involves or compresses.

• Examples: weakness on one side, numbness/tingling, speech difficulty, vision loss in part of the visual field, imbalance, facial droop.
• Why it matters: the pattern of deficits helps estimate tumor location and guides which functions must be protected during surgery.

Cognitive or behavioral changes

Some tumors present subtly: changes in personality, motivation, memory, attention, or judgment. Family members may notice changes before the patient does.

Continue in our app.

• Listen to the audio with the screen off.
• Earn a certificate upon completion.
• Over 5000 courses for you to explore!

Or continue reading below...

Download the app

• Examples: new apathy, irritability, difficulty planning tasks, getting lost in familiar places, word-finding trouble.
• Why it matters: these symptoms can be the most important “baseline” to track after treatment.

Benign vs Malignant, Primary vs Metastatic, and Why Pathology Matters

The word “tumor” describes an abnormal growth, but tumors behave very differently. Understanding a few concepts helps patients make sense of why the workup can feel stepwise and why surgery is often about both diagnosis and treatment.

Benign vs malignant: behavior, not just appearance

• Benign generally means slower-growing and less likely to invade surrounding brain tissue. Some benign tumors can still be dangerous because of their location (for example, near the brainstem) or because they compress critical structures.
• Malignant generally means faster-growing and more likely to infiltrate brain tissue, recur, or spread within the central nervous system. Malignant tumors often require combined treatments (surgery plus radiation and/or chemotherapy).

Primary vs metastatic: where it started

• Primary brain tumors start in the brain or its immediate coverings/structures.
• Metastatic tumors start elsewhere in the body and spread to the brain. In many patients, the primary cancer is already known; in others, a brain lesion may be the first clue.

Why pathology matters (and why imaging alone is not enough)

Imaging can suggest possibilities, but the definitive diagnosis usually comes from examining tumor tissue under a microscope and running molecular tests. This is called pathology.

• Pathology determines: the exact tumor type, grade (how aggressive it appears), and molecular markers that predict behavior and guide therapy.
• Pathology guides the next steps: whether radiation or chemotherapy is recommended, which drug options might work best, and how often follow-up imaging is needed.

In practical terms: two tumors can look similar on MRI but require very different treatments. That is why teams often recommend biopsy or resection when safe and appropriate.

Imaging Features That Guide Suspicion and Surgical Planning

When a brain lesion is found, clinicians interpret imaging in a structured way. The goal is to estimate what the lesion might be, how urgent it is, and how risky it would be to sample or remove.

1) Location: “Where is it and what does that area do?”

• Lobar (frontal, temporal, parietal, occipital): may affect speech, movement, sensation, vision, or behavior depending on the exact region.
• Deep structures: lesions near pathways that carry movement/sensation signals can increase surgical risk.
• Near fluid spaces: tumors that block normal fluid flow can cause pressure symptoms and may need more urgent intervention.

2) Edema (swelling): “How much surrounding brain is irritated?”

Edema can worsen symptoms and can make surgery more challenging because swollen brain tissue is more sensitive. Edema is also a common reason steroids are prescribed before or after surgery.

3) Enhancement: “Does it light up with contrast?”

After contrast is given, some lesions “enhance,” meaning they take up contrast in a way that suggests a disrupted blood-brain barrier. Enhancement patterns can raise suspicion for certain tumor behaviors, but they are not a final diagnosis.

• Practical impact: enhancement can help surgeons identify the most active region to biopsy and can help define targets for resection.

4) Mass effect: “Is it pushing on things?”

Mass effect means the lesion and/or swelling is compressing nearby brain structures. This can correlate with symptoms and urgency.

• Planning impact: significant mass effect may make surgery more urgent; it also influences how the surgical corridor is chosen to minimize additional pressure on healthy brain.

Putting imaging into a patient-friendly checklist

Patients can ask their team to explain the scan using a simple set of questions:

• Where is it? What functions are nearby?
• How big is it? Is it growing compared with prior imaging?
• Is there swelling? Do I need steroids?
• Is it causing pressure? Is this urgent?
• What are the leading possibilities? What would change the plan?

Decision-Making: Observation vs Biopsy vs Resection vs Adjunct Therapies

Once a lesion is identified, the care team weighs diagnosis, safety, symptom control, and long-term outcomes. The plan is individualized, but the options often fall into four categories.

Option A: Observation (watchful waiting)

Observation means monitoring with repeat imaging and symptom tracking rather than immediate surgery.

• When it may be considered: small lesions, minimal/no symptoms, imaging features suggesting a slow-growing process, or when surgical risk is high.
• Step-by-step what observation typically involves:
  • Establish a symptom baseline (headaches, seizures, weakness, speech, memory).
  • Schedule a follow-up MRI at a defined interval.
  • Review for growth, new enhancement, increasing edema, or new symptoms.
  • Revisit the plan if the lesion changes or symptoms evolve.

Option B: Biopsy (tissue diagnosis with minimal removal)

A biopsy obtains a small sample to determine pathology when diagnosis is uncertain or when full removal is not safe or not expected to help.

• Why choose biopsy: to guide radiation/chemotherapy decisions, especially for deep or high-risk locations.
• What patients should understand: biopsy is primarily a diagnostic procedure; it may not relieve pressure or symptoms unless combined with other measures.

Option C: Resection (surgical removal)

Resection aims to remove as much tumor as is safely possible. It can provide tissue diagnosis and, in many cases, improve symptoms by reducing mass effect and irritation.

• Goals of resection:
  • Confirm diagnosis with adequate tissue for modern molecular testing.
  • Reduce tumor burden to improve outcomes and/or make other therapies more effective.
  • Relieve pressure-related symptoms when present.

Option D: Adjunct therapies (radiation and/or chemotherapy)

Radiation and chemotherapy are often used after surgery or biopsy, depending on pathology. Sometimes they are used first if surgery is not safe or if the tumor type is known to respond well.

• How they fit into the plan: surgery reduces tumor burden; adjunct therapies address microscopic disease that cannot be safely removed.

The key principle: “maximal safe resection”

Patients often hear this phrase because it captures the balance neurosurgeons aim for: remove as much tumor as possible without causing unacceptable injury to critical brain functions.

• “Maximal” acknowledges that more removal can matter for symptom relief and long-term control in many tumor types.
• “Safe” acknowledges that the brain is not interchangeable tissue; protecting speech, movement, vision, and cognition is part of the treatment goal.

A practical way to discuss this with the surgeon is to ask: “What function are you most worried about in my case, and how will you protect it?”

Surgical Approaches (Conceptual): How Surgeons Reach and Treat the Tumor

Different tumors require different routes and tools. Even when two patients have “the same kind” of tumor, the surgical plan can differ based on location, size, and proximity to critical networks.

Craniotomy: opening a window to access the brain

A craniotomy is a planned opening in the skull to reach the tumor. The bone is typically replaced at the end of surgery.

• Conceptual steps:
  • Positioning to optimize access and reduce pressure on the brain.
  • Creating a tailored opening based on tumor location.
  • Opening the protective covering (dura) to access the brain.
  • Removing tumor while protecting normal tissue and blood vessels.
  • Closing layers and replacing the bone flap.

Image guidance: “GPS for the brain”

Surgeons often use navigation systems that correlate the patient’s anatomy with preoperative imaging to plan the safest route and to confirm where they are during surgery.

• Why it matters: helps minimize disruption of healthy tissue and improves accuracy when targeting deep or irregular lesions.

Awake mapping principles: protecting speech and movement

When a tumor is near areas responsible for speech or movement, the team may recommend awake mapping. The patient is kept comfortable, and parts of the procedure are done with the patient able to follow commands so the team can test function in real time.

• What mapping is trying to answer: “Is this tissue essential for a function we must preserve?”
• What patients typically do during testing: naming pictures, reading, counting, moving a hand/foot, or answering simple questions.
• Practical benefit: can allow a larger safe removal by clearly identifying boundaries where function is at risk.

Minimally invasive options (when applicable)

Some tumors can be approached with smaller openings or specialized techniques depending on size, location, and goals (diagnosis vs removal). The key idea is not “small incision” but “least disruption while meeting the treatment goal.”

• Examples of when less invasive strategies may be considered: deep lesions where a targeted biopsy is needed, cystic components that can be drained, or carefully selected small tumors in favorable locations.
• Trade-offs to discuss: how much tumor can realistically be removed, whether tissue sampling will be sufficient for full pathology, and what symptoms are expected to improve.

Recovery and Follow-Up: What Happens After Diagnosis and Treatment

Recovery is a process that includes symptom control, healing, rehabilitation when needed, and surveillance to detect recurrence or progression early.

Steroids: reducing swelling and pressure symptoms

Steroids are commonly used to decrease edema around a tumor or after surgery.

• What patients may notice: improved headache or neurologic symptoms as swelling decreases.
• Practical step-by-step:
  • Take exactly as prescribed (dose and timing matter).
  • Do not stop abruptly unless instructed; tapering is often required.
  • Report side effects such as mood changes, insomnia, high blood sugar symptoms, or stomach irritation.

Seizure medications: prevention and safety

If a patient has had a seizure (or the tumor is in a seizure-prone area), antiseizure medication may be prescribed.

• Practical step-by-step:
  • Take doses consistently; missed doses can trigger seizures.
  • Ask about activity restrictions (driving, swimming alone, climbing).
  • Report side effects like severe fatigue, rash, mood changes, or imbalance.

Rehabilitation: getting function back (or learning workarounds)

Some patients benefit from physical therapy, occupational therapy, or speech-language therapy after surgery or during other treatments.

• How rehab is targeted: strength and balance for mobility, fine motor skills for daily tasks, speech/language for communication, and cognitive strategies for attention and memory.
• Practical example: a patient with word-finding difficulty may practice structured naming tasks and learn pacing strategies for conversations.

Surveillance MRIs: monitoring over time

Follow-up imaging is a core part of brain tumor care. The schedule depends on tumor type, treatment received, and stability over time.

• What surveillance looks for: tumor regrowth, treatment effects, changes in enhancement, and evolving edema.
• How patients can prepare: keep a timeline of symptoms and treatments so scan changes can be interpreted in context.

Symptom monitoring: what to track and when to call

Patients and families often provide the earliest warning that something has changed.

• Track: seizures (date/time, duration, triggers), headaches (pattern and severity), new weakness/numbness, speech changes, vision changes, confusion, or personality shifts.
• Seek urgent care for: a prolonged seizure, repeated seizures without recovery, sudden severe headache with vomiting, rapidly worsening weakness or speech, or significant new confusion.